FDA Investigator Kate E Jesse
Kate E Jesse has conducted inspections on 72 sites in 2 countries as of 22 Aug 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
72
Last Inspection Date:
22 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Puerto Rico
FDA Investigators that have inspected at least one site in common with Kate E Jesse:
Aldo J Quintana,
Alexis O Robinson,
Alissa C Rice,
Anetra E Wyatt,
Angel Catala,
Anna M Brannen,
Anthony D Peterson,
Barbara S Manson,
Belinda A Walters,
Carolyn A Ryals,
Carolyn E Barney,
Chantel Evans Dixon,
Charvais S Bogan,
Charvais S Hill,
Cheryl G Scott,
Claire M Minden,
Combs,
Cynthia L Medlin,
Daphne A Videau,
David A Laplante,
David J Leray,
David R Heiar,
Dawn P Hall,
Debra A Sherman,
Debra A Taylor,
Decima L Thompson,
Denise J Taylor,
Diana M Guidry,
Elizabeth D Connell,
Emily E Smith,
Enrique Galan,
Erica L Sullivan,
Erica M Katherine,
Eva I Merced Medina,
Ezra M Taylor,
Gloria J Horner,
Holly I Hall,
Hultman,
Jacquelyn Bradford,
Janice Wai,
Jason D Abel,
Jeffrey R Alling,
Jessica A Stephens,
Jessica Fields,
Karen L Anderson,
Kari L Batey,
Katherine A Bearss,
Katherine A Kellogg,
Kayler L Hudson,
Kimberly D Tucker,
Kimberly J Hoffmeister,
Kimberly L Mcmillan,
Kip J Hanks,
Konsuela Y Glass,
Krista W Whitten,
Larry A Estavan,
Laura M Lopez,
Lawrence A Butler,
Leslie R Morgan,
Lizaida E Rodriguez,
Llopis,
Loreily Figueroa Agrinsoni,
Lorenzo Jones,
Marcus L Head,
Margaret E Slimbach,
Maria A Ruttell,
Mcmillan,
Melanie L Drayton,
Mendoza,
Michael F Mccoy,
Michael T Nehring,
Miguel J Merriweather,
Natalie A Guidry,
Neimar Lopez,
Phuong L Tran,
Ramon H Pabon Aponte,
Randy D Baxter,
Robert E Hultman,
Samantha J Bradley,
Sandricka M Mosley,
Sandy L Atkins,
Scott A Watson,
Shayla G Turnipseed,
Sheila P Barthelemy,
Sheirly J Reyes,
Shirhonda D Thorn,
Sidney M Smith,
Stanley Nelson, Jr,
Stephanie A Cochran,
Thomas B Smith,
Thomas O Morgan,
Thomas R Stanley,
Tiana M Mckinley,
Toby L Keaton,
Tony E Bable,
Traci M Armand,
Wanda B Coats,
Wayne S Fortenberry,
Whitney M White,
Yessica Lopez Villafane
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more